Sign in

CIK 0001619856 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Caribou Biosciences, Inc.

Sign in to watch
Ticker
CRBU
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
453728228
Phone
510-982-6030
Business address
2929 7TH STREET, SUITE 105, BERKELEY, CA, 94710
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-25 Kelly Timothy P Chief Technology Officer Sale −6,228 $1.93 $12K 73,125
2026-02-24 Albertson Tina M. Chief Medical Officer Sale 10b5-1 −1,066 $1.96 $2K 68,523
2026-02-24 Khan Ruhi Ahmad Chief Business Officer Sale −6,938 $1.96 $14K 104,998
2026-02-24 Kelly Timothy P Chief Technology Officer Sale −3,147 $1.96 $6K 79,353
2026-02-24 MCCLUNG BARBARA G Chief Legal Officer Sale −6,938 $1.96 $14K 481,564
2025-02-21 Khan Ruhi Ahmad Chief Business Officer Sale −3,564 $1.35 $5K 66,936
2025-02-21 Kanner Steven Chief Scientific Officer Sale −3,564 $1.35 $5K 431,556
2025-02-21 MCCLUNG BARBARA G Chief Legal Officer Sale −3,564 $1.35 $5K 443,502
2023-01-19 Rizvi Syed Ali-aamir Chief Medical Officer Sale −5,627 $6.31 $36K 59,373
2022-10-06 Fischesser Ryan VP of Finance and Controller Sale −10,000 $10.80 $108K 110,366
2022-08-25 Kanner Steven Chief Scientific Officer Sale −43,248 $11.22 $485K 302,059

Page 1 of 1 · 11 trades